The Drug Enterprise in the Age of AI - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Pharmaceutical Industry in the Era of Artificial Intelligence

  • By

  • kffconnorg

  • November 10, 2026

Share

Objective:

Explore whether AI can generate discoveries for new medicines and examine its role in drug development, regulation, and biomedical research.

Approach:
  • Format: Episode 23 of Chip Kahn’s AI series, presented as a discussion with Dr. Elias Zerhouni.
  • Guest perspective: Zerhouni draws on experience leading the NIH, overseeing global R&D at Sanofi, and co-founding a company using machine learning to design antibodies.
  • Topics: The discussion considers AI’s role in drug development, the FDA compared with overseas regulators, and possible effects of an AI slowdown and declining U.S. research.
Key Findings:
  • Zerhouni argues that AI can accelerate the search for novel medicines but that human insight remains essential to scientific discovery.
  • He illustrates this view by saying that access to all data available in the early 1950s would not have enabled AI to discover the double helix.
Interpretation:

The episode frames AI as a tool that can accelerate drug discovery while emphasizing, in Zerhouni’s view, the continuing role of human creativity.

Limitations:
  • The supplied context is an episode description and biography, not a transcript or research report.
  • It does not provide detailed evidence, methods, or outcomes supporting the claims discussed.
Sources:

Original Source(s)

The Drug Enterprise in the Age of AI

  • by kffconnorg

  • November 10, 2026

Related Content

Redefining Private Practice in Laboratory Medicine

A reflection on the progress, pressures, and changing trends that might threaten the future of pathology

Error in Byline

  • November 9, 2026

Genomics Reveals Causes of Cerebral Palsy

UK pilot study finds that whole genome sequencing can uncover genetic conditions in children, leading to changes in clinical management and specialist care

  • November 6, 2026

  • 2 min